Skip to main content

Arthrodesis

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Paragon 28
Paragon 28CO - Englewood
2 programs
Intramedullary NailN/A1 trial
Small Bone Intramedullary NailN/A1 trial
Active Trials
NCT04084262Completed12Est. May 2022
NCT03257540Terminated8Est. Aug 2018
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Follow-up of Patient Implanted With the Staple ASTUS®N/A1 trial
Active Trials
NCT01518543Terminated5Est. Jan 2013
Stryker
StrykerCA - San Jose
1 program
Radiographic evaluation of previously implanted patientsN/A1 trial
Active Trials
NCT01366989Terminated24Est. Jun 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Paragon 28Intramedullary Nail
Paragon 28Small Bone Intramedullary Nail
StrykerRadiographic evaluation of previously implanted patients
Integra LifeSciencesFollow-up of Patient Implanted With the Staple ASTUS®

Clinical Trials (4)

Total enrollment: 49 patients across 4 trials

NCT04084262Paragon 28Intramedullary Nail

Multi-Plane Hallux Valgus Correction With the Phantom® Nail

Start: Nov 2019Est. completion: May 202212 patients
N/ACompleted
NCT03257540Paragon 28Small Bone Intramedullary Nail

Early Weight-Bearing After Lapidus Arthrodesis

Start: Oct 2017Est. completion: Aug 20188 patients
N/ATerminated
NCT01366989StrykerRadiographic evaluation of previously implanted patients

INBONE Total Ankle Arthroplasty(TAA)Using Calcaneal Stem Fixation

Start: Oct 2010Est. completion: Jun 201324 patients
N/ATerminated
NCT01518543Integra LifeSciencesFollow-up of Patient Implanted With the Staple ASTUS®

Follow-up of Patient Implanted With the Staple ASTUS®

Start: Apr 2010Est. completion: Jan 20135 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.